Hims Says Weight-Loss Shot ‘As Safe’ as Lilly, Novo Drugs (1)

Oct. 30, 2024, 1:26 AM UTC

Hims & Hers Health Inc. said an analysis of more than 10,000 patients taking a copycat version of Novo Nordisk A/S’s Ozempic and Wegovy showed the shot was a safe and effective way to shed pounds.

Patients started off weighing between 200 and 210 pounds, and lost roughly 9.3 pounds on average in the first month, according to the report from the San Francisco-based company. Side effects such as nausea and vomiting were mostly tolerable, it found.

Hims is pushing back on the idea that compounded injections aren’t as safe or beneficial as the brand-name drugs sold by ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.